Enteral Feeding Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

Market Overview

The enteral feeding devices market was valued at approximately USD 2,850 million in 2020 and is expected to witness a revenue of USD 3,985 million in 2026, with a CAGR of 6.2% over the forecast period (2021-2026).

The current pandemic of COVID-19 is expected to significantly impact the enteral feeding devices market globally. According to the research article published in Critical Care, 2020, the SARS-CoV2 virus infects the respiratory tract and is also predicted to invade the gastrointestinal tract, neurological systems, and kidneys, which may affect the nutrition delivery among COVID-19 patients. According to the guidelines by the European Society for Clinical Nutrition and Metabolism (ESPEN) on nutrition in the ICU, Gastric Enteral Nutrition is advised for severe COVID-19 patients and should be preferably performed using a pump with a flow regulator, within 48 hours of admission to the ICU. Hence, the COVID-19 pandemic has increased the need for enteral feeding devices, especially for those in intensive care units, and thus, has been driving the studied market.

The factors that are responsible for the growth of the market include an increasing population of geriatrics, higher premature births, growing adoption of enteral nutrition, and higher prevalence of chronic diseases.

The global population is aging at a fast pace due to reduced birth rates and increasing life expectancy. According to the United Nations’ World Population Ageing 2019 report, there were an estimated 703 million people aged 65 years, globally, in 2019, and this number is expected to reach to 1.5 billion by 2050. As an alternative to conventional nutritional intake, enteral feeding is administered to elderly patients who have difficulty in swallowing, digestion, and assimilation, and thus, this increase of the geriatric population acts as a major factor for the growth of the studied market.

Additionally, according to World Health Organization, 2018, an estimated 15 million babies are born preterm every year and this number is expected to rise over the years. The premature babies have higher nutritional requirements in the neonatal period and early initiation of enteral nutrition could benefit premature babies. Hence, in view of the aforementioned factors, the enteral feeding devices market is expected to witness a significant growth over the forecast period.

Scope of the Report

Enteral feeding refers to the delivery of a nutritionally complete feed, containing protein, carbohydrate, fat, water, minerals, and vitamins, directly into the stomach, duodenum, or jejunum through devices, such as tubes and pumps. It is used for people with functional GI tract, who are not able to ingest foods orally to meet their nutrient demand. The enteral feeding devices market is segmented by product type, age group, end users, application, and geography. By product type, the market is segmented by enteral feeding pumps, enteral feeding tubes, and other product types. By age group, the market is segmented by adults and pediatrics. by end user, the market is segmented by hospitals, ambulatory care services, and other end users. By application, the market is segmented by oncology, neurology, critical care, diabetes, gastroenterology, and other applications. By geography, the market is segmented into North America, Europe, Asia-Pacific, the Middle East and Africa, and South America. The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (in USD million) for the above segments.

Report scope can be customized per your requirements. Click here.

Key Market Trends

Application in Diabetes is Expected to Register a Good Growth during the Forecast Period

For patients with diabetes, the enteral feeding regimen is recommended by the dietitian to meet the individual’s nutritional requirements. Special high-protein diabetes-specific formulas are administered through the enteral feeding tubes, which reduce the insulin need for the patients. This leads to improved glycemic control, which is important for the longevity of the patient. Additionally, enteral nutrition lacks cholesterol and thereby aids in cholesterol control in diabetic patients. The development of insulin resistance can also be minimized using continuous saccharide delivery with appropriate caloric content. According to the research article published in Nutrients, in 2019, the Diabetes- Specific Formula has improved glycemic control through delay in gastric emptying, delayed intestinal absorption of carbohydrate and lower glycemic response, and was found to be effective in increasing High-Density Lipid (HDL) cholesterol levels. Furthermore, as per the research article published in the Lancet, Diabetes, and Endocrinology, 2020, the COVID-19 virus can severely affect diabetic patients as it can precipitate acute metabolic complications through direct negative effects on β-cell function. This impairment on the β-cell function can cause diabetic ketoacidosis in diabetic patients, hyperglycemia at hospital admission in individuals with unknown history of diabetes, and potentially new-onset diabetes, which is expected to surge the demand for enteral feeding devices for the management of diabetes. Hence, COVID-19 is expected to highly impact the studied segment during the pandemic.

Moreover, incidences of diabetes have increased over the years globally, and is expected to increase further. As per a 2019 report by the Internation Diabetes Federation, the global incidence of diabetes is expected to increase from 463 million in 2019 to 578 million by 2030. Thus, these factors play a major role in increasing the demand for enteral feeding devices, which will likely boost the market growth.

To understand key trends, Download Sample Report